Abnormal portal venous flow at sonography predicts reduced survival after transjugular intrahepatic portosystemic shunt creation

Journal of Vascular and Interventional Radiology

Volumn 16, Issue 11, 2005, Pages 1459-1464

  Harrod Kim, Paul ^a   Waldman, David L ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CREATININE;

ADULT; ASCITES; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; HEART INFARCTION; HUMAN; LIVER CELL CARCINOMA; LIVER DISEASE; MALE; MORTALITY; PORTAL VEIN BLOOD FLOW; PORTOSYSTEMIC ANASTOMOSIS; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; SCORING SYSTEM; SODIUM BLOOD LEVEL; STATISTICAL ANALYSIS; SURVIVAL RATE; THROMBUS;

EID: 29544440684     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RVI.0000175328.72653.CA     Document Type: Article

References (16)

1. Rossle M, Haag K, Ochs A, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 1994; 330:165-171.
2. Rossle M, Deibert P, Haag K, et al. Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal bleeding. Lancet 1997; 349:1043-1049.
3. Rossle M, Ochs A, Gulberg V, et al. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med 2000; 342:1701-1707.
4. Salerno F, Merli M, Riggio O, et al. Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites. Hepatology 2004; 40:629-635.
5. Nazarian GK, Bjarnason H, Dietz CA, et al. Refractory ascites: midterm results of treatment with a transjugular intrahepatic portosystemic shunt. Radiology 1997; 205:173-180.
6. Crenshaw WB, Grodon FD, McEniff NJ et al. Severe ascites: efficacy of the transjugular intrahepatic portosystemic shunt in treatment. Radiology 1996; 200:185-192.
7. Malinchoc M, Kamath P, Gordon F, et al. Model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31:864-871.
8. Salerno F, Merli M, Cazzaniga M, et al. MELD score is better than Child-Pugh score in predicting 3-month survival in patients undergoing transjugular intrahepatic portosystemic shunt. J Hepatology 2002; 36:494-500.
9. Ferral H, Gamboa P, Postoak D, et al. Survival after elective transjugular intrahepatic portosystemic shunt creation: prediction with Model for Endstage Liver Disease score. Radiology 2004; 231:231-236.
10. Leen E, Goldberg JA, Anderson JR, et al. Hepatic perfusion changes in patients with liver metastases: comparison with those patients with cirrhosis. Gut 1993; 34:554-557.
11. Lautt WW. Mechanism and role of intrinsic regulation of hepatic arterial blood flow: hepatic arterial buffer response. Am J Physiol 1985; 249(suppl);G549-G556.
12. Kleber G, Steudel N, Behrmann C, et al. Hepatic arterial flow volume and reserve in patients with cirrhosis: use of intra-arterial Doppler and adenosine infusion. Gastroenterology 1999; 116:906-914.
13. Van Beers B, Leconte I, Materne R, et al. Chronic liver disease: dynamic CT measurements correlated with disease severity. Am J Radiol 2001; 176:667-673.
14. Walser E, DeLa Pena R, Villanueva-Meyer J, et al. Hepatic perfusion before and after the transjugular intrahepatic portosystemic shunt procedure: impact on survival. J Vasc Interv Radiol 2000; 11:913-918.
15. Walser E, Ozkan O, Raza S, et al. Hepatic perfusion as a predictor of mortality after transjugular intrahepatic portosystemic shunt creation in patients with refractory ascites. J Vasc Interv Radiol 2003; (14):1251-1257.
16. Heuman DM, Abou-assi SG, Habib A, et al. Persistent Ascites and Low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology 2004; 40:802-810.